Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ImmunityBio (IBRX) Other Operating Expenses: 2020-2023

Historic Other Operating Expenses for ImmunityBio (IBRX) over the last 3 years, with Dec 2023 value amounting to $886,000.

  • ImmunityBio's Other Operating Expenses was N/A to $177,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $886,000 for FY2023, which is 30.10% up from last year.
  • ImmunityBio's Other Operating Expenses amounted to $886,000 in FY2023, which was up 30.10% from $681,000 recorded in FY2022.
  • In the past 5 years, ImmunityBio's Other Operating Expenses registered a high of $10.7 million during FY2020, and its lowest value of $681,000 during FY2022.
  • In the last 2 years, ImmunityBio's Other Operating Expenses had a median value of $783,500 in 2022 and averaged $783,500.
  • Data for ImmunityBio's Other Operating Expenses shows a peak YoY spiked of 30.10% (in 2023) over the last 5 years.
  • Over the past 3 years, ImmunityBio's Other Operating Expenses (Yearly) stood at $10.7 million in 2020, then reached $681,000 in 2022, then surged by 30.10% to $886,000 in 2023.